Chemotactic activity of culture supernatants of free and encapsulated pancreatic rat islets towards peritoneal macrophages

Hormone and Metabolic Research

Volumn 31, Issue 8, 1999, Pages 448-454

  Karsten, V ^a   Lencioni, C ^b   Tritschler, S ^a   Marchetti, P ^b   Belcourt, A ^a   Navalesi, R ^b   Alexandre, E ^c   Poindron, Ph ^a   Pinget, M ^a   Kessler, L ^a,d  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Istituto di Fisiologia Clinica   (Italy)

^c Fondation Transplantation   (France)

^d Pavillon Leriche   (France)

Author keywords

Artificial Membrane; Bioartificial Pancreas; Cell Migration; Chemotactic Factor; Leucocyte

Indexed keywords

GLUCOSE; INSULIN; PROTEINASE K;

ACINAR CELL; ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CHEMOTAXIS; CONTROLLED STUDY; ENCAPSULATION; FIBROBLAST; IMMUNOGENICITY; MACROPHAGE MIGRATION; MALE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT;

EID: 0032867379     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978773     Document Type: Article

References (39)

1. + macrophage and not a T lymphocyte. Transplantation 1995; 60: 594-601
2. 2 Colton CK. Engineering challenges in cell-encapsulation technology. Trends in biotechnology 1996; 14: 158-162
3. 3 Lanza RP, Chick WL. Immunoisolation: at a turning point, Immunol Today 1997; 3: 135-139
4. 4 Andersson A, Eizirik DL, Bremer C, Johnson RC, Pipeleers DG, Hellerström C. Structure and function of macroencapsulated human and rodent pancreatic islets transplanted into nude mice. Horm Metab Res 1996; 28: 306-309
5. 5 Jain K, Yang H, Cai BR, Haque B, Hurvitz AI, Diehl C, Miyata T, Smith BH, Stenzel K, Suthanthiran M, Rubin A. Retrieveable, replaceable, macroencapsulated pancreatic islet xenografts. Transplantation 1995; 59: 319-324
6. 6 Lanza RP, Kühtreiber WM, Ecker D, Staruk JE, Chick WL. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 1995; 59: 1377-1384
7. 7 Sharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, Gentile FT, Flavin KS, Ansara MF, Lacy PE. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 1994; 43: 1167-1170
8. 8 Soon-Shiong P, Feldman E, Nelson R, Heintz R, Yao Q, Yao Z, Tianli Z, Merideth N, Skjak-Braek G, Espevik T, Smidsrod O, Sandford P. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad Sci 1993; 90: 5843-5847
9. 9 Kessler L, Jesser C, Lombard Y, Karsten V, Belcourt A, Pinget M, Poindron Ph. Cytotoxicity of peritoneal murine macrophages against encapsulated pancreatic rat islets: in vivo and in vitro studies. J Leukoc Biol 1996; 60: 729-736
10. 10 Zekorn TDC, Endl U, Horcher A, Siebers U, Bretzel RG, Federlin K. Evidence for an antigen-release induced cellular immune response against alginate-polylysine encapsulated islets. Xenotransplantation 1995; 2: 116-119
11. 11 Weber C, Ayres-Price J, Costanzo M, Becker A, Stall A. Nod mouse peritoneal cellular response to poly-L-lysine alginate microencapsulation rat islets. Transplant Proc 1994; 26: 1116-1119
12. 12 Horcher A, Zekorn T, Siebers U, Klöck G, Franck H, Houben R, Bretzel RG, Zimmermann U, Federlin K. Transplantation of microencapsulated islets in rats: evidence for induction of fibrotic overgrowth by islet alloantigens released from microcapsules. Transplant Proc 1994; 26: 784-786
13. 13 Lacy PE, Kostianovsky M. Method for isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967; 16: 35-39
14. 14 Lake PL, Anderson J, Chamberlain J, Gardner SJ, Bell PRF, James RFL. Bovine serum albumin density gradient isolation of rat pancreatic islets. Transplantation 1987; 43: 805-808
15. 15 Jesser C, Kessler L, Lambert A, Belcourt A, Pinget M. Pancreatic islet macroencapsulation: a new device for the evaluation of artificial membrane. Artif Organs 1996; 20: 977-1007
16. 16 Kedinger M, Simon-Assman P, Alexandre E, Haffen C. Importance of a fibroblastic support for in vitro differenciation of intestinal endodermal cells and for their response to glucocorticoids. Cell differ 1987; 20: 171-182
17. 17 Boyden S. The chemotactic effect of mixtures of antibody and antigens on polymorphonuclear leucocytes. J Exp med 1962; 115: 453-466
18. 18 Zigmond SH, Hirsch JE. Leucocyte locomotion and chemotaxis. New methods for evaluation and demonstration of a cell derived chemotactic factor. J Exp Med 1972; 137: 387-410
19. 19 Siebers U, Endl U, Horcher A, Bretzel RG, Federlin K, Zekorn T. Evaluation of the effect of microencapsulation and immunomodulation on islet immunogenicity in vitro. Exp Clin Endocrinol Diabetes 1995; 103: 140-142
20. 20 Marquet RL, Bonthuis F, Duval SY, De Bruin RWF, Van Rooijen N, Scheringa M, Ijzermans JNM. Macrophages and nitric oxide are involved in primary nonfunction of islet xenografts. Transplant Proc 1995; 27: 252-253
21. 21 Weber C, Krekun S, Koschitzky T, Zabinski S, D'Agati V, Hardy M, Reemtsma K. Prolonged functional survival of rat-to NOD mouse islet xenografts by ultraviolet-B (UV-B) irradiation plus microencapsulation of donor islets. Transplant Proc 1991; 23: 764-766
22. 22 Gill RG, Wolf L. Immunobiology of cellular transplantation. Cell Transplant 1995; 4: 361-370
23. 23 Zekorn TDC, Horcher A, Mellert J, Siebers U, Altug T, Emre A, Hahn H-J, Federlin K. Biocompatibility and immunology in the encapsulation of islets of Langerhans (bioartificial pancreas). Int J Artif Organs 1996; 19: 251-257
24. 24 Colton CK, Avgoustiniatos ES. Bioengineering in development of the hybrid artificial pancreas. J Biomech Eng 1991; 113: 152-170
25. 25 Pueyo ME, Darquy S, Capron F, Reach G. In vitro activation of human macrophages by alginate-polylysine microcapsules. J Biomater Sci Polymer Edn 1993; 5: 197-203
26. 26 Peluso G, Petillo O, Ranieri M, Santin M, Ambrosio L, Calabro D, Avallone B, Balsamo G. Chitosan-mediated stimulation of macrophage function. Biomaterials 1994; 15: 1215-1220
27. 27 Hunt JA, Flanagan BF, McLaughlin PL, Strickland I, Williams DF. Effect of biomaterial surface charge on the inflammatory response: evaluation of cellular infiltration and TNFα production. J Biomed Mat Res 1996; 31: 139-144
28. 28 Otterlei M, Ostgaard K, Skjak-Braek G, Smidrod O, Soon-Shiong P, Espevik T. Induction of cytokine production from human monocytes stimulated with alginate. J Immunother 1991; 10: 286-291
29. 29 Espevik T, Otterlei M, Skjak-Braek G, Ryan L, Wright SD, Sundan A. The involvement of CD14 in stimulation of cytokine production by uronic polymers. Eur J Immunology 1993; 23: 255-261
30. 30 Kessler L, Legeay G, Jesser C, Damgé C, Pinget M. Influence of corona surface treatment on the properties of an artificial membrane used for Langerhans islets encapsulation: permeability and biocompatibility studies. Biomaterials 1995; 16: 185-191
31. 31 Kessler L, Jesser C, Belcourt A, Pinget M. Influence of acinar tissue contamination on encapsulated pancreatic islets. Transplantation 1997; 63: 1537-1540
32. 32 Nicolae M, Ketchum RJ, Jahr H, Janoff H, Brayman KL. Islet xenografts in mice and rats: exocrine tissue is detrimental to engraftment and survival of human islets xenografts. Transplant Proc 1994; 26: 774
33. 33 Gray DWR, Sutton R, McShane P, Peter SM, Moris PJ. Exocrine contamination impairs implantation of pancreatic islets transplanted beneath the kidney capsule. J Surg Res 1988; 45: 432-442
34. 34 Meyer JE, Berner I, Teran LM, Bartels J, Sticherling M, Schroder JM, Maune S. RANTES production by cytokine-stimulated nasal fibroblasts: its inhibition by glucocorticoids. Int Arch Allergy Immunol 1998; 117: 60-67
35. 35 Radomsky ML, Thompson AY, Spiro RC, Poser JW. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop 1998; 335: S283-293
36. 36 Laskin DL, Soltys RA, Berg RA, Riley DJ. Activation of alveolar macrophages by native and synthetic collagen-like polypeptides. Am J Respir Cell Mol Biol 1994; 10: 58-64
37. 37 Muir A, Rovin BH, Lacy PE, Schreiner GF. Macrophage-specific chemotactic lipid release by in vivo streptozotocin-administered mouse islets. Diabetes 1991; 40: 1459-1466
38. 38 Josefsen K, Nielsen H, Hansen WA, Kristensen JK, Bilde T, Bendtzen K, Buschard K. Tissue culture supernatants from human islets of Langerhans activate the oxidative burst response of human monocytes in vitro. Life Science 1995; 56: 1333-1342
39. 39 Leiter EH. Murine macrophages and pancreatic β cells. Chemotactic properties of insulin and β cytostatic action of interleukin 1. J Exp Med 1987; 166: 1174-1179